2 studies found for:    18523152 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Condition: Malignant Melanoma, Metastatic
Interventions: Biological: Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF);   Biological: Ipilimumab
2 Active, not recruiting Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
Conditions: Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Biological: ipilimumab;   Biological: sargramostim;   Other: pharmacological study;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years